Lv3
280 积分 2025-11-30 加入
Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies
10小时前
已完结
Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention
12小时前
已完结
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions
12小时前
已完结
Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy
12小时前
已完结
Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention
12小时前
已完结
Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials
12小时前
已完结
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol– or Apolipoprotein B–Related Risk of Coronary Heart Disease
1天前
已完结
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
1天前
已完结
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention
2天前
已完结
Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention
2天前
已完结
皖公网安备34019202002308
